info@synchemia.com | sales@synchemia.com 
9766925136 
Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Related Products
N-Nitroso Ripretinib Impurity 1
| CAT No | SRC-N0141127 |
| CAS No | NA |
| Mol.F. | C8H8ClN3O2 |
| Mol.Wt. | 213.6 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Ripretinib Impurity 2
| CAT No | SRC-N0141128 |
| CAS No | NA |
| Mol.F. | C17H15BrFN5O2 |
| Mol.Wt. | 420.2 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Tofacitinib Impurity 5 | M- 1749 Desbenzyl nitrosamine Impurity
| CAT No | SRC-N0141129 |
| CAS No | NA |
| Mol.F. | C14H21N3O |
| Mol.Wt. | 247.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
N-Nitroso 5,6-Dihydro Tofacitinib
| CAT No | SRC-N0141130 |
| CAS No | NA |
| Mol.F. | C16H21N7O2 |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Tofacitinib Impurity 6
| CAT No | SRC-N0141131 |
| CAS No | NA |
| Mol.F. | C10H16N4O2 |
| Mol.Wt. | 224.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Tofacitinib Impurity 7 | M-1749 Nitrosamine Impurity
| CAT No | SRC-N0141132 |
| CAS No | NA |
| Mol.F. | C7H15N3O |
| Mol.Wt. | 157.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
N-Nitroso Tofacitinib Impurity 8
| CAT No | SRC-N0141133 |
| CAS No | NA |
| Mol.F. | C7H15N3O |
| Mol.Wt. | 157.2 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Tofacitinib Impurity 9
| CAT No | SRC-N0141134 |
| CAS No | NA |
| Mol.F. | C7H14N4O2 |
| Mol.Wt. | 186.2 |
| INV STATUS | CUSTOM SYNTHESIS |
Tofacitinib N-Oxide Impurity 5
| CAT No | SRC-N0141135 |
| CAS No | NA |
| Mol.F. | C13H18N6O |
| Mol.Wt. | 274.3 |
| INV STATUS | CUSTOM SYNTHESIS |
Tofacitinib N-Oxide Impurity 6
| CAT No | SRC-N0141136 |
| CAS No | NA |
| Mol.F. | C20H24N6O |
| Mol.Wt. | 364.5 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Tofacitinib Impurity 2
| CAT No | SRC-N0141137 |
| CAS No | NA |
| Mol.F. | C16H22N6O2 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
Tofacitinib Nitroso Impurity 2
| CAT No | SRC-N0141138 |
| CAS No | NA |
| Mol.F. | C15H17N7O2 |
| Mol.Wt. | 327.3 |
| INV STATUS | CUSTOM SYNTHESIS |
Tofacitinib Nitroso Impurity 3
| CAT No | SRC-N0141139 |
| CAS No | NA |
| Mol.F. | C16H19N7O2 |
| Mol.Wt. | 341.4 |
| INV STATUS | CUSTOM SYNTHESIS |
Tofacitinib Nitroso Impurity 4
| CAT No | SRC-N0141140 |
| CAS No | NA |
| Mol.F. | C17H20N6O2 |
| Mol.Wt. | 340.4 |
| INV STATUS | CUSTOM SYNTHESIS |
Sitagliptin Nitroso Impurity 2
.png)
| CAT No | SRC-N0141141 |
| CAS No | NA |
| Mol.F. | C6H7F3N6O3 |
| Mol.Wt. | 268.2 |
| INV STATUS | CUSTOM SYNTHESIS |
Velpatasvir Nitroso Impurity 4
| CAT No | SRC-N0141142 |
| CAS No | NA |
| Mol.F. | C39H44N8O6 |
| Mol.Wt. | 720.8 |
| INV STATUS | CUSTOM SYNTHESIS |
